Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

INDUSTRY × Liver Cirrhosis × Tenofovir × Clear all

Status

No longer available 1

Sponsor Class

Study Type

Expanded_access 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Fibrosis 2 Carcinoma, Hepatocellular 2 Liver Cirrhosis 1 Hepatitis D 1 Hepatitis B, Chronic 1 Hepatitis B 1 Esophageal and Gastric Varices 1

Interventions

peginterferon alfa-2a 1 hepatitis C immune globulin, human 1 Tenofovir 1 Rosuvastatin Calcium 1 Immunoglobulin G 1 Furosemide 1 Digoxin 1 Cannabidiol 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05683548 2025-02-17

RCAP

Replicor Inc.

No longer available

Gastrointestinal

Hepatitis D, Esophageal and Gastric Varices, Fibrosis, Hepatitis B, Carcinoma, Hepatocellular, Liver Cirrhosis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡